Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Effect of elexacaftor/tezacaftor/ivacaftor on the use of routine therapies in Danish people with cystic fibrosis

Effect of elexacaftor/tezacaftor/ivacaftor on the use of routine therapies in Danish people with cystic fibrosis

Resource Type

CF Research News

Authors

Hans Kristian Råket, Camilla Bjørn Jensen, Joanna Nan Wang, Tacjana Pressler, Hanne Vebert Olesen, Marianne Skov, Søren Jensen-Fangel, Janne Petersen, Espen Jimenez-Solem; TransformCF study group

References

J Cyst Fibros. 2024 Nov 23:S1569-1993(24)01813-7. doi: 10.1016/j.jcf.2024.11.004.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Drug utilization [3]
registry [4]
Treatment Outcome [5]

Date

Saturday, November 23, 2024

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/effect-elexacaftortezacaftorivacaftor-use-routine-therapies-danish

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-24-00198R2_FINAL_Pedersen_151224.pdf [2] https://pubmed.ncbi.nlm.nih.gov/39581783/ [3] https://www.ecfs.eu/research-article-keywords/drug-utilization [4] https://www.ecfs.eu/research-article-keywords/registry [5] https://www.ecfs.eu/research-article-keywords/treatment-outcome [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines